[Inhalation therapy with Respimat soft inhaler in patients with COPD and asthma]

Area of Science:

• Respiratory Medicine
• Medical Device Engineering

Context:

• Obstructive pulmonary diseases require effective and convenient inhalation devices.
• Existing inhaler technologies, including propellant-driven metered-dose inhalers (pMDI) and dry powder inhalers (DPI), have limitations.
• There is a continuous need for improved drug delivery systems for respiratory conditions.

Purpose:

• To introduce the Respimat Soft Inhaler (Respimat SI) as a novel inhalation device.
• To address the drawbacks associated with conventional pMDIs and DPIs.
• To evaluate the technical attributes and performance of the Respimat SI.

Summary:

• The Respimat SI utilizes mechanical energy from a spring to atomize a water-based solution through a fine nozzle, creating a slow-moving mist.
• This mist has a high fine particle fraction, promoting excellent lung deposition and reducing oropharyngeal deposition.
• The device operates independently of patient inspiratory flow and does not require propellants or batteries, simplifying coordination and use.

Impact:

• The Respimat SI represents a significant advancement in inhalation technology.
• It offers improved lung deposition and ease of use compared to existing devices.
• The device potentially enhances treatment efficacy for patients with obstructive pulmonary diseases.